Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Artificial intelligence to identify equine ocular disease
Artificial intelligence could lead to more horses getting an earlier diagnosis.
The tool can diagnose moon blindness in horses.

An artificial intelligence (AI) tool could be used to diagnose equine recurrent uveitus (ERU) in horses.

The inflammatory ocular disease, also known as ‘moon blindness’, can lead to blindness or loss of the affected eye.

ERU is one of the more common eye diseases in horses, and can have a major economic impact. A quick, correct diagnosis can minimise the lasting damage.

The research team created an AI tool, which was trained with photographs of diseases to identify the patterns which may lead to a diagnosis.

To assess the efficacy of their deep learning tool, researchers from the Ludwig-Maximilian-Universität München asked 150 veterinary surgeons to evaluate 40 photos of horses’ eyes. The pictures included a mixture of healthy eyes, eyes with ERU, and eyes with other diseases.

Equine veterinary surgeons completed the test with a 76 per cent success rate, meanwhile veterinary surgeons working in small animal or mixed practice identified the eye issues correctly 67 per cent of the time.

When the AI image analysis tool was given the same challenge, the probability of receiving the correct answer was 93 per cent.

The researchers say that, while the difference was not statistically significant, it proved that AI could reliably recognise ERU. This could support veterinary surgeons with the diagnosis of potential emergency cases.

This could lead to more horses getting an earlier diagnosis, increasing the likelihood of them receiving prompt treatment and saving affected eyes. It will also enable less experienced veterinary surgeons to differentiate between ERU and other opthalmic diseases.

The AI, deep learning tool is web-app based, and can be used through a smartphone device.

Professor Anna May, who led the research team, said: "It's not meant to replace veterinarians, but can help them reach the correct diagnosis.

“It is particularly valuable for less experienced professionals or for horse owners in regions where vets are few and far between,"

The full study can be found in the Equine Veterinary Journal.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.